Diagnosed at age 32, a former patient speaks out to help other women know the signs and symptoms of cervical cancer — and to get scree
A Michigan Medicine gastroenterologist has studied why patients skip the lifesaving test.
One cancer patient’s immunotherapy clinical trial, an approach with hopeful results, could have implications for others seeking treatment.
Rose Mary Worthen wasn’t expected to live more than a year after her diagnosis.
Five years of endocrine therapy or 10? As breast cancer patients weigh the benefits of long-term treatment, a new study might help.